Skip to main content

Global sources of cryoprecipitate demonstrate variability in coagulant factor levels and functional hemostasis.

Publication ,  Journal Article
Evans, BA; Kamyszek, RW; Piegore, M; Stoner, K; Fuller, M; Welsby, IJ; Mooberry, M
Published in: Blood Coagul Fibrinolysis
March 1, 2021

Cryoprecipitate (cryo) is a plasma-derived blood product utilized during trauma resuscitation, surgery, and other major bleeding. Although local quality control metrics exist, inherent donor variability, and processing may confer differences in hemostatic effect between sources. The purposes of this study were to quantify procoagulant content in three global sources of cryo and evaluate their functional hemostatic effect. In this Institutional Review Board exempt study, 24 units of group A cryo from three different sources, American Red Cross single donor and pooled donor, Australian Red Cross single donor, Southwestern United States single donor, and Southwest pooled donor, were evaluated. Procoagulant factors were quantified from each source using ELISA and automated clot-based assays. Functional hemostasis was evaluated using rotational Thromboelastometry (ROTEM). Microparticles isolated from cryo units were enumerated and evaluated for cellular origin by flow cytometry, as well as their capacity to support thrombin generation. Southwestern United States single donor units demonstrated highest levels of fibrinogen, fibronectin, factor VIII, and von Willebrand factor in the selected units. In the coagulopathy model, successive doses from all cryo units were significantly correlated to decreasing coagulation time (P = 0.0100), and increasing maximum clot firmness (P = 0.0002) and alpha angle (P = 0.0009). Southwest pooled donor demonstrated significantly shorter coagulation time at all three doses (P = 0.02) than other sources. Microparticles support prothrombinase activity and thrombin generation. In this study of global cryo sources, procoagulant activity and in-vitro clot formation varied by source. This could be explained by variance in production and storage protocols. Further study is warranted to assess functional variance in cryo to optimize and standardize the use of cryo products.

Duke Scholars

Published In

Blood Coagul Fibrinolysis

DOI

EISSN

1473-5733

Publication Date

March 1, 2021

Volume

32

Issue

2

Start / End Page

87 / 102

Location

England

Related Subject Headings

  • Humans
  • Hemostasis
  • Fibrinogen
  • Factor VIII
  • Coagulants
  • Cardiovascular System & Hematology
  • Blood Donors
  • Blood Coagulation Tests
  • Blood Coagulation Factors
  • Blood Coagulation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Evans, B. A., Kamyszek, R. W., Piegore, M., Stoner, K., Fuller, M., Welsby, I. J., & Mooberry, M. (2021). Global sources of cryoprecipitate demonstrate variability in coagulant factor levels and functional hemostasis. Blood Coagul Fibrinolysis, 32(2), 87–102. https://doi.org/10.1097/MBC.0000000000000982
Evans, Brooke A., Reed W. Kamyszek, Mark Piegore, Keaton Stoner, Matthew Fuller, Ian J. Welsby, and Micah Mooberry. “Global sources of cryoprecipitate demonstrate variability in coagulant factor levels and functional hemostasis.Blood Coagul Fibrinolysis 32, no. 2 (March 1, 2021): 87–102. https://doi.org/10.1097/MBC.0000000000000982.
Evans BA, Kamyszek RW, Piegore M, Stoner K, Fuller M, Welsby IJ, et al. Global sources of cryoprecipitate demonstrate variability in coagulant factor levels and functional hemostasis. Blood Coagul Fibrinolysis. 2021 Mar 1;32(2):87–102.
Evans, Brooke A., et al. “Global sources of cryoprecipitate demonstrate variability in coagulant factor levels and functional hemostasis.Blood Coagul Fibrinolysis, vol. 32, no. 2, Mar. 2021, pp. 87–102. Pubmed, doi:10.1097/MBC.0000000000000982.
Evans BA, Kamyszek RW, Piegore M, Stoner K, Fuller M, Welsby IJ, Mooberry M. Global sources of cryoprecipitate demonstrate variability in coagulant factor levels and functional hemostasis. Blood Coagul Fibrinolysis. 2021 Mar 1;32(2):87–102.

Published In

Blood Coagul Fibrinolysis

DOI

EISSN

1473-5733

Publication Date

March 1, 2021

Volume

32

Issue

2

Start / End Page

87 / 102

Location

England

Related Subject Headings

  • Humans
  • Hemostasis
  • Fibrinogen
  • Factor VIII
  • Coagulants
  • Cardiovascular System & Hematology
  • Blood Donors
  • Blood Coagulation Tests
  • Blood Coagulation Factors
  • Blood Coagulation